Rudolf Peceny

1.8k total citations
20 papers, 822 citations indexed

About

Rudolf Peceny is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Rudolf Peceny has authored 20 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Rudolf Peceny's work include Hematopoietic Stem Cell Transplantation (9 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Eosinophilic Disorders and Syndromes (4 papers). Rudolf Peceny is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Eosinophilic Disorders and Syndromes (4 papers). Rudolf Peceny collaborates with scholars based in Germany, Switzerland and United States. Rudolf Peceny's co-authors include Dietrich W. Beelen, Ahmet Elmaağaclı, Rudolf Trenschel, Hellmut Ottinger, Hans Grosse‐Wilde, S. Ferenčík, Michael Koldehoff, Nina K. Steckel, Monika Lindemann and U. W. Schaefer and has published in prestigious journals such as Blood, Transplantation and Leukemia.

In The Last Decade

Rudolf Peceny

19 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rudolf Peceny Germany	13	587	358	159	153	108	20	822
Terry Flood United Kingdom	17	314 0.5×	441 1.2×	111 0.7×	128 0.8×	136 1.3×	31	766
Akira Ishiwata Japan	15	293 0.5×	263 0.7×	94 0.6×	167 1.1×	118 1.1×	23	666
Craig Howe United States	9	714 1.2×	302 0.8×	145 0.9×	100 0.7×	186 1.7×	13	909
Eugenia Giraldi Italy	11	518 0.9×	171 0.5×	87 0.5×	288 1.9×	247 2.3×	22	885
Tiziana Zei Italy	11	706 1.2×	705 2.0×	99 0.6×	89 0.6×	252 2.3×	26	1.1k
Michelle Abboud United States	8	367 0.6×	207 0.6×	173 1.1×	63 0.4×	114 1.1×	15	535
ED Thomas United States	14	634 1.1×	229 0.6×	143 0.9×	108 0.7×	177 1.6×	28	841
James M. Coghill United States	14	508 0.9×	666 1.9×	69 0.4×	115 0.8×	193 1.8×	38	925
Maria Bieniaszewska Poland	11	261 0.4×	550 1.5×	163 1.0×	107 0.7×	207 1.9×	34	877
Hirotoshi Sakaguchi Japan	13	442 0.8×	108 0.3×	204 1.3×	312 2.0×	65 0.6×	51	752

Countries citing papers authored by Rudolf Peceny

Since Specialization

Citations

This map shows the geographic impact of Rudolf Peceny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Peceny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Peceny more than expected).

Fields of papers citing papers by Rudolf Peceny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Peceny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Peceny. The network helps show where Rudolf Peceny may publish in the future.

Co-authorship network of co-authors of Rudolf Peceny

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf Peceny. A scholar is included among the top collaborators of Rudolf Peceny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf Peceny. Rudolf Peceny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koch, Raphael, Joachim Gerß, Marcus Hentrich, et al.. (2022). A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy. Annals of Hematology. 102(1). 63–72. 1 indexed citations

Shumilov, Evgenii, Petra Hoffknecht, Raphael Koch, et al.. (2021). Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers. Cancers. 13(12). 2917–2917. 2 indexed citations

Köhler, Wolfgang, Philipp Hemmati, Christian Jehn, et al.. (2019). Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X‐linked adrenoleukodystrophy. Journal of Inherited Metabolic Disease. 42(2). 313–324. 16 indexed citations

Peceny, Rudolf, et al.. (2014). Peripheral Progenitor Cell Graft in the Rat: A Technique of Graft Processing. Ajakirjad. Journals by UT. 34(4). 269–278.

Schnittger, Susanne, Christiane Eder, Sabine Jeromin, et al.. (2012). ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia. 27(1). 82–91. 153 indexed citations

Ditschkowski, Markus, Ahmet Elmaağaclı, Rudolf Trenschel, et al.. (2007). T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica. 92(4). 558–561. 39 indexed citations

Elmaağaclı, Ahmet, Michael Koldehoff, Nina K. Steckel, et al.. (2006). Mutations in Innate Immune System NOD2/CARD 15 and TLR-4 (Thr399Ile) Genes Influence the Risk for Severe Acute Graft-versus-Host Disease in Patients Who Underwent an Allogeneic Transplantation. Transplantation. 81(2). 247–254. 105 indexed citations

Elmaağaclı, Ahmet, Hellmut Ottinger, Michael Koldehoff, et al.. (2005). Reduced Risk for Molecular Disease in Patients with Chronic Myeloid Leukemia after Transplantation from a KIR-Mismatched Donor. Transplantation. 79(12). 1741–1747. 31 indexed citations

Elmaağaclı, Ahmet, Michael Koldehoff, Rudolf Peceny, et al.. (2005). WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.. PubMed. 90(3). 326–34. 38 indexed citations

10.

Trenschel, Rudolf, Markus Ditschkowski, AH Elmaagacli, et al.. (2005). Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation. Bone Marrow Transplantation. 35(6). 583–586. 22 indexed citations

11.

Koldehoff, Michael, Dietrich W. Beelen, Rudolf Trenschel, et al.. (2004). Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia. Bone Marrow Transplantation. 34(12). 1047–1050. 36 indexed citations

12.

Beelen, Dietrich W., Hellmut Ottinger, S. Ferenčík, et al.. (2004). Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood. 105(6). 2594–2600. 138 indexed citations

13.

Ottinger, H., S. Ferenčík, Dietrich W. Beelen, et al.. (2004). Impact of HLA-A,B,C Allele Mismatches on Outcome after Unrelated Blood Stem Cell Transplantation in Whites. Transplantation. 78(7). 1077–1080. 12 indexed citations

14.

Trenschel, Rudolf, Markus Ditschkowski, Ahmet Elmaağaclı, et al.. (2004). Myeloablative Treosulfan as Preparative Regimen for Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Experience.. Blood. 104(11). 3343–3343. 1 indexed citations

15.

Ottinger, Hellmut, S. Ferenčík, Dietrich W. Beelen, et al.. (2003). Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood. 102(3). 1131–1137. 81 indexed citations

16.

Basu, Oliver, et al.. (2002). Allogeneic CD34+-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases. Bone Marrow Transplantation. 29(1). 9–13. 6 indexed citations

17.

Elmaağaclı, Ahmet, Rudolf Peceny, Rudolf Trenschel, et al.. (2002). Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia. Blood. 99(4). 1130–1135. 55 indexed citations

18.

Elmaağaclı, Ahmet, Rudolf Peceny, Nina K. Steckel, et al.. (2002). Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia. Blood. 101(2). 446–453. 55 indexed citations

19.

Beelen, DW, Rudolf Peceny, Ahmet Elmaağaclı, et al.. (2000). Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study. Bone Marrow Transplantation. 26(8). 823–829. 12 indexed citations

20.

Trenschel, Rudolf, et al.. (2000). Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Bone Marrow Transplantation. 26(9). 993–997. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact